MDR-06155

N/A

Report date: 2024/12/02 11:06:07
NME

Base Information

Drug NameMDR-06155
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesNastech Pharmaceutical Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNastech Pharmaceutical Company Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A